您当前所在位置:首页 > 材料科学 > 新品上市
序号 标题 次数 作者 发布时间
84061 Boc-Val-Cit cas:870487-08-4 196 zyl 2024-12-19
84062 cas:663598-66-1,1-((4-((5-Nitropyridin-2-yl)disulfanyl)pentanoyl)oxy)-2,5-dioxopyrrolidine-3-sulfonic acid 160 wyh 2024-12-19
84063 cas:870487-10-8,Boc-Val-Cit-PAB-PNP,BOC-VAL-CIT-PAB-PNP 酯 146 kx 2024-12-19
84064 cas:2353409-69-3 Mal-PEG8-Val-Cit-PAB-MMAE 202 zyl 2024-12-19
84065 cas:108852-90-0 Nemorubicin 奈莫柔比星 174 zyl 2024-12-19
84066 cas:159858-22-7 , Fmoc-Val-Cit-PAB-OH,ADC(抗体偶联药物) 150 kx 2024-12-19
84067 cas:1626359-59-8 磺基-SPDB-DM4 126 zyl 2024-12-19
84068 cas:870487-09-5,Boc-Val-Cit-PAB, ADC试剂 120 kx 2024-12-19
84069 NH2-Glu-Gly-Cit-PAB-OH, ADC试剂 201 kx 2024-12-19
84070 sulfo-SPDB-DGN462,用于提高化合物的水溶性和稳定性 239 WYQ 2024-12-19
84071 Fmoc-Gly-Gly-Phe-Gly-OH, ADC试剂 183 kx 2024-12-19
84072 1342211-31-7,MC-Val-Ala-OH,马来酰亚胺基己酰-L-缬氨酰-L-丙氨酸,ADC连接子多肽 210 kx 2024-12-19
84073 MA-PEG4-VC-PAB-DMAE-PNU159682(CAS号:2259318-52-8) 155 WYQ 2024-12-19
84074 MC-vc-PAB-C6-a-amanitin,一种抗体药物偶联物(ADC) 182 WYQ 2024-12-19
84075 cas:690632-55-4,N-Succinimidyloxycarbonylpropyl Methanethiosulfonate 106 wyh 2024-12-19
84076 VC-MMAF(CAS号:863971-17-9) 151 WYQ 2024-12-19
84077 cas:159857-70-2 MC-Val-Cit-Doxorubicin-ADC抗体偶联药物 122 zyl 2024-12-19
84078 2055024-62-7,NH2-PEG3-Val-Cit-PAB-OH, ADC试剂 137 kx 2024-12-19
84079 cas:1834516-06-1 Fmoc-Ala-Ala-Asn-PABC-PNP 144 zyl 2024-12-19
84080 perfluorophenyl 1-(1,3-dioxoisoindolin-2-yloxy)-3,6,9,12-tetraoxapentadecan-15-oate 171 wyh 2024-12-19
84081 MC -Val-Cit, ADC试剂 205 kx 2024-12-19
84082 cas:141534-26-1,2-(4-formylbenzamido)ethyl nitrate 206 wyh 2024-12-19
84083 cas:159857-81-5 Mc-Val-Cit-PABC-PNP 150 zyl 2024-12-19
84084 MC-PEG4-va-PAB-Exatecan, ADC试剂 305 kx 2024-12-19
84085 cas:2101206-44-2 PY-DS-DMBUT-OPFP 179 zyl 2024-12-19
84086 Perfluorophenyl 3-(2-(2-(4-formylbenzamido)ethoxy)ethoxy)propanoate 121 wyh 2024-12-19
84087 SMCC-DM4(CAS号:1228105-52-9) 148 WYQ 2024-12-19
84088 NHS ester-PEG4-VC-PAB-Dxd, ADC试剂 335 kx 2024-12-19
84089 cas:53053-08-0,4-azidobenzoic acid N-hydroxysuccinimide ester 123 wyh 2024-12-19
84090 N3-Linker-Gefitinib,Gefitinib本身具有*肿瘤活性 187 WYQ 2024-12-19
84091 Boc-Val-Cit-OH的介绍 158 zyl 2024-12-19
84092 mDPR-Val-Ala-PAB-MMAE, ADC试剂 200 kx 2024-12-19
84093 Boc-Val-Ala-PAB-OC2H5 | ADC Linker 176 zyl 2024-12-19
84094 cas:2259318-56-2,DBCO-PEG4-VC-PAB-DMAE-PNU159682, ADC试剂 168 kx 2024-12-19
84095 Mc-Dexamethasone,CAS号:1618096-56-2 172 WYQ 2024-12-19
84096 N3-PEG4-YPYDVPDYA-Doxorubicin,抗体偶联药物(ADC)的一部分 192 WYQ 2024-12-19
84097 DBCO-PEG4-VA-PAB-EDA-N-Ac-Calicheamicin,ADC定制 226 kx 2024-12-19
84098 N3-PEG4-DYKDDDD-Doxorubicin,抗体偶联药物(ADC)的一部分 175 WYQ 2024-12-19
84099 Azide-hex-vc-PAB-EDA-Biotin的介绍 271 zyl 2024-12-19
84100 Fmoc-PEG4-Val-Ala-PAB-PNP,具有类似的可降解性、生物相容性和定向运输特性 179 WYQ 2024-12-19
84101 DBCO-PEG4-vc-PAB (PEG2)- Duocarmycin SA,ADC定制 179 kx 2024-12-19
84102 Mal-Ala-Ala-PAB-PNP的介绍 308 zyl 2024-12-19
84103 Fmoc-PEG4-Val-Ala-PAB,合成抗体偶联药物(ADC) 147 WYQ 2024-12-19
84104 BODIPY-erythromycin,ADC定制 212 kx 2024-12-19
84105 MA-PEG4-Glu-Val-Cit-PAB-PNP 178 zyl 2024-12-19
库存查询